Current portal location

Website content

Meetings

ACCESS TO MEDICINES AND TRIPs

  • Date: 26/09/2007, 09:00-13:00 (Registration closed)
  • Location: Berlaymont Building, room Jean Monnet, reu de la Loi 200 - 1040 Brussels
  • Registration closes on : 21/09/2007 12:00

Meeting details

  • Date: 26/09/2007, 09:00-13:00 (registration closed)
  • Location: Berlaymont Building, room Jean Monnet, reu de la Loi 200 - 1040 Brussels
  • Registration closes on : 21/09/2007 12:00

Date: 26/09/2007
Time: 09.00 – 13.00
Location: Berlaymont Building, room Jean Monnet, rue de la Loi 200, 1040 Brussels

Purpose of the meeting: The meeting will focus on the follow-up of the Intergovernmental Working Group on public health, innovation and intellectual property rights (IGWG) of the World Health Organisation (WHO) and in particular on the IGWG's Draft global strategy and plan of action on public health, innovation and intellectual property (A/PHI/IGWG/2/2). More information on the IGWG and on the draft global strategy and action plan is available here .

The meeting will feature a series of panel discussions with the participation of relevant Commission services and civil society organisations. After each panel, the floor will be open for questions.


LEAD PARTICIPANTS
- Ms Marianne Gumaelius, Mr Domenico Fornari, DG Trade
- Ms Nicola Robinson, DG Health and Consumer Protection
- Mr Juan Garay, DG Development
- Ms Suzanne Kodsi , Mr Jose Valente, DG EuropeAid
- Ms Claudia Colla, DG Internal Market and Services
- Mr Denis Dambois Mr Albrecht Jahn, DG Research and Development
- Ms Alexandra Heumber, Medecins sans Frontières (MSF)
- Mr Brendan Barnes, European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Ms Michelle Childs, Knowledge Ecology International


AGENDA

1. Introduction by External Trade

2. Panel discussions

2.1 Access to medicines, including IP management for access and improving delivery of access
Panellists: Ms M. Gumaelius, Mr D. Fornari, Ms N. Robinson, Mr J. Garay, Ms S. Kodsi , Mr J.Valente, Ms Cl. Colla, Ms A. Heumber, Mr B. Barnes

2.2 Technology transfer and capacity building
Panellists: Mr D. Dambois, Ms A. Heumber, Mr B. Barnes

2.3 Priority setting and sustainable systems of finance for priority Research &Development
Panellists: Mr J. Garay, Ms M. Childs, Mr B. Barnes

2.4 Intellectual property incentives and other pull mechanisms, such as price, patent buyout, etc.
Panellists: Ms Mr A. Jahn, Ms M. Childs, Mr B. Barnes

About travel expense.

Related documents

Organisations that have registered to participate in this meeting.

  • Mrs Anna Brodowski, European Federation of Pharmaceutical Industries and Associations
  • Dr Wim De Ceukelaire, Medical Aid for the Third World
  • Ms Ciara Goldstein, The Global Alliance for TB Drug Development
  • Mr Jose Luis Gutiérrez-Aranda, Africa Europe Faith and Justice Network
  • Mr Joseph Jimenez, European Federation of Pharmaceutical Industries and Associations
  • Ms Marta Monteso, ActionAid
  • Mr Robert Shaw, ActionAid